# Karyopharm Therapeutics Inc.: Form DEF 14A, filed Dec 16, 2024

- Company: [Karyopharm Therapeutics Inc.](/companies/kpti.md) (CIK 1503802)
- Form: DEF 14A
- Filed: 2024-12-16
- Accepted by EDGAR: Dec 16, 2024, 16:00 ET
- Period: 2025-01-30
- Accession: 0000950170-24-136598
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1503802/000095017024136598/kpti-_2025_spec_meeting-.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1503802/000095017024136598/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1503802/000095017024136598/kpti-_2025_spec_meeting-.htm

Filed Dec 16, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-136598. Last ingested by Listed: Nov 3, 2026, 06:05 ET. No prices; not investment advice.